$AURX Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Nuo Therapeutics, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Nuo Therapeutics, Inc.. Get notifications about new insider transactions in Nuo Therapeutics, Inc. for free.

Page: 1 2 3 4 4 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 03 2019	AURX	Nuo Therapeutics, ...	Atinsky Lawrence	Director	Option Exercise	A	0.40	62,500	25,000	62,500
Jan 03 2019	AURX	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO, CFO	Option Exercise	A	0.40	125,000	50,000	125,000
Jan 03 2019	AURX	Nuo Therapeutics, ...	Mintz Paul	Director	Option Exercise	A	0.40	50,000	20,000	50,000
Jan 03 2019	AURX	Nuo Therapeutics, ...	Pittman Scott M.	Director	Option Exercise	A	0.40	62,500	25,000	62,500
Jan 03 2019	AURX	Nuo Therapeutics, ...	CLAUSEN PETER	CSO	Option Exercise	A	0.40	81,250	32,500	81,250
Jan 03 2019	AURX	Nuo Therapeutics, ...	WINZER C ERIC	Director	Option Exercise	A	0.40	68,750	27,500	68,750
Aug 13 2018	AURX	Nuo Therapeutics, ...	Pittman Scott M.	Director	Option Exercise	A	0.40	121,875	48,750	121,875
Aug 13 2018	AURX	Nuo Therapeutics, ...	Atinsky Lawrence	Director	Option Exercise	A	0.40	109,375	43,750	109,375
Aug 13 2018	AURX	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO, CFO	Option Exercise	A	0.40	192,710	77,084	192,710
Aug 13 2018	AURX	Nuo Therapeutics, ...	WINZER C ERIC	Director	Option Exercise	A	0.40	120,313	48,125	120,313
Aug 13 2018	AURX	Nuo Therapeutics, ...	CLAUSEN PETER	CSO	Option Exercise	A	0.40	183,853	73,541	183,853
Aug 13 2018	AURX	Nuo Therapeutics, ...	Mintz Paul	Director	Option Exercise	A	0.40	87,500	35,000	87,500
Sep 21 2017	NUOT	Nuo Therapeutics, ...	Boyalife Investment Fund I, In ...	10% Owner	Buy	P	0.22	3,150,000	699,930	4,900,000	1.8 M to 4.9 M (+180.00 %)
Aug 14 2017	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO, CFO	Buy	P	0.22	247,500	54,995	557,146	309.6 K to 557.1 K (+79.93 %)
Aug 14 2017	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Buy	P	0.50	560,000	280,000	2,935,800	2.4 M to 2.9 M (+23.57 %)
Aug 14 2017	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Buy	P	0.22	1,485,000	329,967	2,375,800	890.8 K to 2.4 M (+166.70 %)
Aug 14 2017	NUOT	Nuo Therapeutics, ...	SHEEDY CHARLES E	10% Owner	Buy	P	0.22	5,220,000	1,159,884	8,286,312	3.1 M to 8.3 M (+170.24 %)
Jul 10 2017	NUOT	Nuo Therapeutics, ...	Mintz Paul	Director	Option Exercise	A	1.00	18,750	18,750	18,750
Jan 11 2017	NUOT	Nuo Therapeutics, ...	CLAUSEN PETER	CSO	Option Exercise	A	1.00	80,000	80,000	80,000
Jan 11 2017	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO, CFO	Option Exercise	A	1.00	162,500	162,500	162,500
Jan 11 2017	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Option Exercise	A	1.00	40,000	40,000	40,000
Jan 11 2017	NUOT	Nuo Therapeutics, ...	Atinsky Lawrence	Director	Option Exercise	A	1.00	40,000	40,000	40,000
Jan 11 2017	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Option Exercise	A	1.00	40,000	40,000	40,000
Jan 11 2017	NUOT	Nuo Therapeutics, ...	WINZER C ERIC	Director	Option Exercise	A	1.00	40,000	40,000	40,000
Oct 07 2016	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Buy	J	0.00	27,859	0	305,160	277.3 K to 305.2 K (+10.05 %)
Aug 23 2016	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Option Exercise	P	1.00	280,000	280,000	280,000
Aug 23 2016	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Option Exercise	P	0.75	850,000	637,500	850,000
Aug 23 2016	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Buy	J	0.00	10,000	0	890,800	880.8 K to 890.8 K (+1.14 %)
Aug 15 2016	NUOT	Nuo Therapeutics, ...	SHEEDY CHARLES E	10% Owner	Buy	J	0.00	10,000	0	3,066,312	3.1 M to 3.1 M (+0.33 %)
Aug 15 2016	NUOT	Nuo Therapeutics, ...	SHEEDY CHARLES E	10% Owner	Buy	J	0.00	10,000	0	3,066,312	3.1 M to 3.1 M (+0.33 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	WINZER C ERIC	Director	Buy	P	1.00	25,000	25,000	25,000	0 to 25 K
Jul 29 2016	NUOT	Nuo Therapeutics, ...	CLAUSEN PETER	Chief Scientific Of ...	Buy	J	0.00	3,474	0	3,474	0 to 3.5 K
Jul 29 2016	NUOT	Nuo Therapeutics, ...	CLAUSEN PETER	Chief Scientific Of ...	Buy	J	0.00	1,201	0	1,201	0 to 1.2 K
Jul 29 2016	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Buy	J	0.00	189	0	880,800	880.6 K to 880.8 K (+0.02 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Buy	J	0.00	21,483	0	880,611	859.1 K to 880.6 K (+2.50 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Buy	J	0.00	34,128	0	859,128	825 K to 859.1 K (+4.14 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Buy	P	1.00	525,000	525,000	825,000	300 K to 825 K (+175.00 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	Pittman Scott M.	Director	Buy	P	1.00	300,000	300,000	300,000	0 to 300 K
Jul 29 2016	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Buy	J	0.00	27,301	0	277,301	250 K to 277.3 K (+10.92 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Buy	P	1.00	250,000	250,000	250,000	0 to 250 K
Jul 29 2016	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO and CFO	Buy	J	0.00	167	0	167	0 to 167
Jul 29 2016	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO and CFO	Buy	J	0.00	55,915	0	309,646	253.7 K to 309.6 K (+22.04 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO and CFO	Buy	J	0.00	62,182	0	253,731	191.5 K to 253.7 K (+32.46 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO and CFO	Buy	J	0.00	54,049	0	191,549	137.5 K to 191.5 K (+39.31 %)
Jul 29 2016	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	CEO and CFO	Buy	P	1.00	137,500	137,500	137,500	0 to 137.5 K
Jul 15 2015	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Acting CFO	Option Exercise	A	0.21	250,000	52,500	430,000
May 13 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.27	50,000	13,500	13,139,215	13.2 M to 13.1 M (-0.38 %)
Mar 12 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	15,850	5,548	13,189,215	13.2 M to 13.2 M (-0.12 %)
Mar 12 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	1,200	420	13,205,065	13.2 M to 13.2 M (-0.01 %)
Mar 12 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Buy	J	1.18	1,270,000	1,498,600	13,206,265	11.9 M to 13.2 M (+10.64 %)
Mar 12 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	J	0.00	105,300	0	11,936,265	12 M to 11.9 M (-0.87 %)
Jan 22 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	5,500	1,925	12,181,395	12.2 M to 12.2 M (-0.05 %)
Jan 15 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	153,467	53,713	12,186,895	12.3 M to 12.2 M (-1.24 %)
Jan 15 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	14,000	4,900	12,340,362	12.4 M to 12.3 M (-0.11 %)
Jan 12 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	73,496	25,724	12,354,362	12.4 M to 12.4 M (-0.59 %)
Jan 12 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	61,037	21,363	12,427,858	12.5 M to 12.4 M (-0.49 %)
Jan 12 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	82,850	28,998	12,488,895	12.6 M to 12.5 M (-0.66 %)
Jan 12 2015	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Option Exercise	A	0.34	45,000	15,300	491,364
Jan 12 2015	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Option Exercise	A	0.61	30,000	18,300	446,364
Jan 06 2015	NUOT	Nuo Therapeutics, ...	McLoughlin Mark T	Director	Option Exercise	A	0.34	45,000	15,300	435,000
Jan 06 2015	NUOT	Nuo Therapeutics, ...	HOHNKE LYLE A	Director	Option Exercise	A	0.34	45,000	15,300	620,000
Jan 06 2015	NUOT	Nuo Therapeutics, ...	WINZER C ERIC	Director	Option Exercise	A	0.34	45,000	15,300	285,000
Jan 06 2015	NUOT	Nuo Therapeutics, ...	KEITH STEPHEN	Director	Option Exercise	A	0.34	45,000	15,300	285,000
Jan 02 2015	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	100	35	12,571,745	12.6 M to 12.6 M (0.00 %)
Dec 31 2014	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	299,900	104,965	12,571,845	12.9 M to 12.6 M (-2.33 %)
Dec 31 2014	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	100	35	12,871,745	12.9 M to 12.9 M (0.00 %)
Dec 23 2014	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.37	10,300	3,811	12,871,845	12.9 M to 12.9 M (-0.08 %)
Dec 23 2014	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	97,150	34,003	12,882,145	13 M to 12.9 M (-0.75 %)
Dec 23 2014	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	S	0.35	2,850	998	12,979,295	13 M to 13 M (-0.02 %)
Oct 08 2014	NUOT	Nuo Therapeutics, ...	TOZER DEAN	Chief Commercial Of ...	Buy	P	0.36	33,300	11,988	200,000	166.7 K to 200 K (+19.98 %)
Sep 16 2014	NUOT	Nuo Therapeutics, ...	TOZER DEAN	Chief Commercial Of ...	Buy	P	0.45	40,000	18,000	166,700	126.7 K to 166.7 K (+31.57 %)
Sep 02 2014	NUOT	Nuo Therapeutics, ...	TOZER DEAN	Chief Commercial Of ...	Buy	P	0.35	40,000	14,000	126,700	86.7 K to 126.7 K (+46.14 %)
Aug 27 2014	NUOT	Nuo Therapeutics, ...	SHALLCROSS STEVEN A	Chief Financial Off ...	Buy	P	0.38	27,500	10,450	79,500	52 K to 79.5 K (+52.88 %)
Aug 25 2014	NUOT	Nuo Therapeutics, ...	TOZER DEAN	Chief Commercial Of ...	Buy	P	0.38	38,700	14,706	86,700	48 K to 86.7 K (+80.63 %)
Aug 21 2014	NUOT	Nuo Therapeutics, ...	TOZER DEAN	Chief Commercial Of ...	Buy	P	0.39	48,000	18,720	48,000	0 to 48 K
Aug 21 2014	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Buy	P	0.40	25,000	10,000	229,149	204.1 K to 229.1 K (+12.25 %)
Aug 21 2014	NUOT	Nuo Therapeutics, ...	SHALLCROSS STEVEN A	Chief Financial Off ...	Buy	P	0.39	52,000	20,280	52,000	0 to 52 K
Apr 10 2014	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	CHIEF EXECUTIVE OFF ...	Option Exercise	A	0.60	2,624,800	1,574,880	3,655,023
Apr 10 2014	NUOT	Nuo Therapeutics, ...	Field Edward L.	CHIEF OPERATING OFF ...	Option Exercise	A	0.60	1,285,900	771,540	1,819,900
Apr 10 2014	NUOT	Nuo Therapeutics, ...	SHALLCROSS STEVEN A	SEE REMARKS	Option Exercise	A	0.60	1,219,900	731,940	1,819,900
Feb 07 2014	NUOT	Nuo Therapeutics, ...	McLoughlin Mark T	Director	Option Exercise	A	0.61	30,000	18,300	420,000
Jan 30 2014	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Option Exercise	A	0.61	30,000	18,300	30,000
Jan 30 2014	NUOT	Nuo Therapeutics, ...	WINZER C ERIC	Director	Option Exercise	A	0.61	40,000	24,400	240,000
Jan 30 2014	NUOT	Nuo Therapeutics, ...	KEITH STEPHEN	Director	Option Exercise	A	0.61	40,000	24,400	240,000
Jan 30 2014	NUOT	Nuo Therapeutics, ...	HOHNKE LYLE A	Director	Option Exercise	A	0.61	40,000	24,400	575,000
Apr 19 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.50	15,000	7,500	6,875,000	6.9 M to 6.9 M (+0.22 %)
Apr 19 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.51	20,000	10,200	6,860,000	6.8 M to 6.9 M (+0.29 %)
Apr 19 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.51	15,000	7,650	6,840,000	6.8 M to 6.8 M (+0.22 %)
May 21 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.50	55,000	27,500	6,905,000	6.9 M to 6.9 M (+0.80 %)
May 21 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.50	25,000	12,500	6,850,000	6.8 M to 6.9 M (+0.37 %)
Apr 09 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.52	31,515	16,388	6,825,000	6.8 M to 6.8 M (+0.46 %)
Apr 09 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.51	43,485	22,177	6,793,485	6.8 M to 6.8 M (+0.64 %)
Apr 05 2013	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Buy	P	0.52	17,231	8,960	204,149	186.9 K to 204.1 K (+9.22 %)
Mar 21 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Option Exercise	A	0.51	30,000	15,300	30,000
Mar 20 2013	NUOT	Nuo Therapeutics, ...	WINZER C ERIC	Director	Option Exercise	A	0.51	40,000	20,400	200,000
Mar 20 2013	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Option Exercise	A	0.51	30,000	15,300	580,362
Mar 20 2013	NUOT	Nuo Therapeutics, ...	HOHNKE LYLE A	Director	Option Exercise	A	0.51	30,000	15,300	535,000
Mar 20 2013	NUOT	Nuo Therapeutics, ...	McLoughlin Mark T	Director	Option Exercise	A	0.51	40,000	20,400	390,000
Mar 20 2013	NUOT	Nuo Therapeutics, ...	Benson James	Director	Option Exercise	A	0.51	30,000	15,300	380,000
Mar 20 2013	NUOT	Nuo Therapeutics, ...	KEITH STEPHEN	Director	Option Exercise	A	0.51	40,000	20,400	200,000
Feb 27 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.53	4,400	2,332	6,750,000	6.7 M to 6.8 M (+0.07 %)
Feb 27 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.52	20,600	10,712	6,745,600	6.7 M to 6.7 M (+0.31 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Option Exercise	P	0.75	19,091	14,318	19,091
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Option Exercise	P	0.75	12,727	9,545	12,727
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Option Exercise	P	0.75	63,636	47,727	63,636
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Option Exercise	P	0.75	63,636	47,727	63,636
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Option Exercise	P	0.75	22,567	16,925	22,567
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Option Exercise	P	0.75	15,616	11,712	15,616
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Buy	P	0.55	27,273	15,000	39,967	12.7 K to 40 K (+214.85 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Buy	P	0.55	18,182	10,000	60,494	42.3 K to 60.5 K (+42.97 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Buy	P	0.55	90,909	50,000	429,404	338.5 K to 429.4 K (+26.86 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Buy	P	0.55	90,909	50,000	175,533	84.6 K to 175.5 K (+107.43 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Buy	P	0.55	32,238	17,731	157,276	125 K to 157.3 K (+25.78 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Buy	P	0.55	22,308	12,269	108,830	86.5 K to 108.8 K (+25.78 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Option Exercise	P	0.75	224,849	168,637	224,849
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Option Exercise	P	0.75	224,848	168,636	224,848
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Option Exercise	P	0.75	215,020	161,265	215,020
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Option Exercise	P	0.75	9,829	7,372	9,829
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Buy	P	0.55	321,213	176,667	1,233,740	912.5 K to 1.2 M (+35.20 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Buy	P	0.55	321,211	176,666	1,233,738	912.5 K to 1.2 M (+35.20 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Buy	P	0.55	307,171	168,944	1,179,805	872.6 K to 1.2 M (+35.20 %)
Feb 26 2013	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Buy	P	0.55	14,042	7,723	53,934	39.9 K to 53.9 K (+35.20 %)
Feb 22 2013	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Buy	P	0.53	20,000	10,600	186,918	166.9 K to 186.9 K (+11.98 %)
Feb 22 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.53	20,000	10,600	6,725,000	6.7 M to 6.7 M (+0.30 %)
Feb 22 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.53	30,000	15,900	6,705,000	6.7 M to 6.7 M (+0.45 %)
Feb 21 2013	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Option Exercise	P	0.75	356,364	267,273	520,362
Feb 21 2013	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Buy	P	0.55	509,091	280,000	1,143,770	634.7 K to 1.1 M (+80.21 %)
Feb 21 2013	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Option Exercise	P	0.70	114,286	80,000	620,110
Feb 15 2013	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Sell	J	0.00	557,671	0	12,982,145	13.5 M to 13 M (-4.12 %)
Sep 14 2012	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.89	25,000	22,250	6,675,000	6.7 M to 6.7 M (+0.38 %)
Sep 12 2012	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	P	0.95	8,333	7,916	6,650,000	6.6 M to 6.7 M (+0.13 %)
Sep 04 2012	NUOT	Nuo Therapeutics, ...	McLoughlin Mark T	Director	Option Exercise	X	0.00	6,667	0	350,000
Sep 04 2012	NUOT	Nuo Therapeutics, ...	McLoughlin Mark T	Director	Buy	X	0.00	6,667	0	20,001	13.3 K to 20 K (+50.00 %)
Aug 31 2012	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Option Exercise	X	0.00	16,667	0	505,824
Aug 31 2012	NUOT	Nuo Therapeutics, ...	JORDEN DAVID EMERSON	Director	Buy	X	1.00	16,667	16,667	6,641,667	6.6 M to 6.6 M (+0.25 %)
Aug 08 2012	NUOT	Nuo Therapeutics, ...	Maslan Andrew Scott	Chief Financial Off ...	Option Exercise	X	0.00	10,000	0	462,643
Aug 08 2012	NUOT	Nuo Therapeutics, ...	Maslan Andrew Scott	Chief Financial Off ...	Buy	X	1.00	10,000	10,000	112,780	102.8 K to 112.8 K (+9.73 %)
Aug 07 2012	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Option Exercise	X	0.00	16,667	0	1,096,997
Aug 07 2012	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Gift	G	1.65	8,000	13,200	166,918	174.9 K to 166.9 K (-4.57 %)
Aug 07 2012	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Buy	X	1.00	16,667	16,667	174,918	158.3 K to 174.9 K (+10.53 %)
Jul 03 2012	NUOT	Nuo Therapeutics, ...	Maslan Andrew Scott	CHIEF FINANCIAL OFF ...	Buy	P	1.08	5,000	5,400	102,780	97.8 K to 102.8 K (+5.11 %)
Jul 03 2012	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Buy	P	1.15	8,000	9,200	158,251	150.3 K to 158.3 K (+5.32 %)
Jun 20 2012	NUOT	Nuo Therapeutics, ...	DEL GUERCIO JOSEPH	Director	Option Exercise	A	1.88	30,000	56,400	193,998
Jun 20 2012	NUOT	Nuo Therapeutics, ...	Kent Richard S	Director	Option Exercise	A	1.88	30,000	56,400	986,426
May 22 2012	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Option Exercise	C	0.00	135,398	0	0
May 22 2012	NUOT	Nuo Therapeutics, ...	Aldagen Holdings, LLC	10% Owner	Buy	C	0.00	13,539,816	0	13,539,816	0 to 13.5 M
Jun 19 2012	NUOT	Nuo Therapeutics, ...	HOHNKE LYLE A	Director	Option Exercise	A	1.88	30,000	56,400	505,000
May 04 2012	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Option Exercise	P	1.42	4,071	5,781	1,080,330
May 04 2012	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Option Exercise	X	0.00	17,922	0	1,076,259
May 04 2012	NUOT	Nuo Therapeutics, ...	ROSENDALE MARTIN P	Chief Executive Off ...	Buy	X	0.54	17,922	9,621	150,251	132.3 K to 150.3 K (+13.54 %)

Page: 1 2 3 4 4 next >